Pecans may help lower cholesterol, new study suggests
NCT ID NCT05949879
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether eating different amounts of pecans every day for 28 days can improve cholesterol and other heart health markers in adults who are overweight or have high cholesterol. 108 participants were split into groups that ate pecans providing 6%, 13%, or 20% of their daily calories, or stuck to their usual diet. Researchers measured blood fats, sugar, and appetite-related hormones before and after a high-fat meal to see how pecans affect the body's response.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- pecans
- What this could lead to
- If it works, this could show that adding pecans to your diet helps lower cholesterol and improve heart health.
- What could go wrong
- This is a small, completed dietary study, not a drug trial. Results may not apply to everyone, and eating too many pecans could add extra calories.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
108 people
The number who actually took part.
- Started
-
Aug 2023
- Finished
-
Apr 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
30 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * 30 to 75-year-old men and women at increased risk of cardiovascular disease. Increased risk of cardiovascular disease will be defined by either elevated cholesterol profiles or overweight/obesity. * Elevated cholesterol profiles will be defined as: "Borderline High" and/or "at risk" in two or more of the following variables (total cholesterol: 180-239 mg/dL, LDL cholesterol 110- 159 mg/dL, triglycerides 130-199 mg/dL) --or---"High" in total cholesterol (240 mg/dL and higher), LDL (160 mg/dL or higher), or triglycerides (between 200-350 mg/dl). * Overweight/obesity will be defined by body mass index (overweight \> 28 kg/m2 or obesity 30 kg/m2 or greater). Exclusion Criteria: * Probable familial hypercholesterolemia, defined by: total cholesterol greater than 290 mg/dL or LDL levels greater than 190 mg/dL plus a family history of myocardial infarction (MI) before 50 years of age in a 2nd-degree relative or below age 60 in a 1st-degree relative * Alcohol intake \>3 drinks/d for males or \>2 drinks/d for females * Individuals with food allergies/sensitivities to foods provided in the study, including tree nuts, gluten, and or lactose/dairy * Individuals who regularly consume nuts and/or nut butter (defined as consumption of \>2 servings (\~56g) of tree nuts, nuts, or nut butter (e.g., peanut butter, almond butter) per week * Individuals adhering to special diets, including, but not limited to, the ketogenic diet, intermittent fasting, vegetarian diet, or carbohydrate-restricted diets * Plans to begin a weight loss/exercise regime during the trial * Weight gain or loss of more than 5% of their body weight in the past 3 months * History of previous or current renal or bowel disease * Females who are currently pregnant or lactating * Individuals participating in \>3 hours/week of exercise * Women on hormone replacement therapy for \<2 years * Fasting glucose \>126 mg/dL * Blood pressure \>180/120 mmHg * History of medical or surgical events that could affect digestion or swallowing * Gastrointestinal surgery, atherosclerosis, or bleeding disorders * Tobacco or nicotine use * Previous heart attack (MI) or stroke, previous or current diagnosis of cancer * Chronic or metabolic diseases * Medication use affecting digestion and absorption, medications affecting metabolism (e.g., thyroid meds), lipid-lowering medications, medications for diabetes, blood thinning medications * Steroid/hormone therapies or current antibiotic cycles
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Dyslipidemias are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Georgia
Athens, Georgia, 30602, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can cottonseed oil improve cholesterol? trial tests common cooking oil against similar blends
- Can Weight-Loss surgery weaken protein digestion in older adults?
- Can pole walking boost heart fitness in diabetic patients?
- Weight loss after cancer: a new program aims to help survivors
- Healthy meals at work: a recipe for better eating?
- Amino acid may shield aging muscles during dieting